Can-fite Biopharma Ltd. balance sheet

At the end of fiscal 2025, Can-fite Biopharma Ltd. had total assets of $9.5m and shareholders' equity of $5.6m. It held $5.5m in cash against $0 of debt.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Can-fite Biopharma Ltd.: balance sheet, annual
Fiscal year	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Cash and equivalents	4	3	8	4	3	4	5	6
Total current assets	—	7	9	20	9	10	9	9
Total assets	—	8	10	20	9	10	9	10
Deferred revenue (current)	—	0	0	1	1	1	0	0
Total current liabilities	—	3	1	3	3	2	2	3
Total debt	0	0	0	0	0	0	0	0
Shareholders' equity	3	2	6	14	4	6	5	6
Shares outstanding	—	181m	—	—	408m	—	—	—

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: CANF vs CRVO CANF vs CRDF CANF vs CLNN

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Can-fite Biopharma Ltd.'s SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Can-fite Biopharma Ltd.